METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 302.00
+1.00 (0.33%)
Jan 9, 2026, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 51.88 billion as of January 9, 2026. Its market cap has increased by 14.07% in one year.
Market Cap
51.88B
Enterprise Value
110.16B
Revenue
28.10B
Ranking
n/a
PE Ratio
40.55
Stock Price
302.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 51.88B, an increase of 30.29%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 51.88B | -0.98% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |